Olvi Oyj walked into its Q3 2026 report with the stock already under pressure, down about 14% over the past month and 16% over ninety days to close at €27.5 on Thursday. The headline result was solid rather than spectacular. Quarterly revenue landed at €209.2m and net income reached €20.6m, keeping earnings per share at €1. That mix created a sharp contrast between the share price slide and an income statement that still supports a 9% trailing net margin and a low P/E, which keeps the longer term valuation story very much alive.
Like the earnings strength at Olvi Oyj but uneasy about the recent share price slide and what it might signal for similar consumer stocks? Check out our shortlist built from the 191 high quality undervalued stocks to compare this setup with other companies that combine resilient profitability with compressed valuations.
Q3 2026 Earnings Summary
- Revenue (Q3 2026 vs. Q3 2025): €209.228m vs. €186.207m (up about 12.4%)
- Net Income (Excl. Extra Items, Q3 2026 vs. Q3 2025): €20.553m vs. €20.226m (broadly flat, up about 1.6%)
- Basic EPS (Q3 2026 vs. Q3 2025): €1.00 vs. €0.98 (up about 2%)
- Trailing Net Profit Margin (TTM, Q3 2026 vs. Q3 2025): 9% vs. 8.2% (margin improved by about 0.8 percentage points)
Prefer clear visual charts to scanning endless rows of figures? Explore Olvi Oyj’s full financial picture, including how the valuation compares with its recent earnings, in our company report for Olvi Oyj.
Olvi’s expansion thesis earns partial validation
Bulls argue that Olvi Oyj’s heavy outlay on new markets and capacity will translate into healthy, profitable scale rather than stranded assets.
"The main thing that has to go right is that Olvi Oyj turns recent acquisitions and high investment in production, logistics and systems into sustained, profitable growth in both alcoholic and non-alcoholic beverages across its expanded footprint."
Q2 and H1 show real progress. Volumes rose, pricing and mix lifted net sales, and EBIT grew faster than sales, helped by a roughly 42% gross margin. Rest of Europe EBITDA improved and new markets like Sweden and Norway added higher price points. The guidance cut to €80–85m EBIT, and delayed Varska impact, show the volume and profit ramp is slower and lumpier than that upbeat script suggests.
Rest of Europe risks still firmly on the table
The bear story focuses on Rest of Europe, where misfiring operations could turn growth projects into a drag on Olvi Oyj’s earnings power.
"Despite management efforts to reposition Denmark from private label to own-brand products, the operation remains loss-making with no improvement in profitability and continues to drag on Rest of Europe EBIT, so any further underutilization or delay in the turnaround could keep group EBIT closer to the lower end of guidance ranges and cap future earnings growth."
Recent data lines up with that warning. Denmark is still loss making, with low capacity use and lost private label business, and management again tightened EBIT guidance lower to €80–85m, explicitly citing weaker Rest of Europe performance. Rest of Europe EBITDA did rise almost 11%, yet organic volumes in that region excluding acquisitions fell, so the turnaround is not yet visible. The market reaction, with the share price down about 16% over 90 days to €27.5, suggests investors are treating these execution issues as live and unresolved rather than legacy noise.
One Narrative has put a figure on that disagreement. → See the Narrative with its higher Fair Value, assumptions and all.
Hunt For Quiet Disconnects
Olvi Oyj just showed how a solid income statement can coexist with a sliding share price. The real opportunity sits in finding stocks that could be undervalued before the market adjusts.
- Company 1 - 44% below our estimate - targets higher aircraft build rates by rolling out composite structures tied to its efficiency program and capital investments.
- Company 2 - 31% below our estimate - anchors digital infrastructure by supplying custom silicon and connectivity hardware that large customers rely on to keep critical data moving securely.
- Company 3 - 29% below our estimate - expands assembly and testing lines so new facilities can handle higher value AI focused memory and mixed signal workloads.
Those are three of them. See the full list of 191 companies trading below our fair value estimates →
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com